JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, F. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Berger, F. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 96, Issue 3, 213-223, 1949
Copyright © 1949 by American Society for Pharmacology and Experimental Therapeutics


THE PHARMACOLOGICAL PROPERTIES OF 2-METHYL,2-n-AMYL-4-HYDROXYMETHYL-1,3-DIOXOLANE (GLYKETAL), A NEW BLOCKING AGENT OF INTERNEURONS

F. M. Berger 1

1 Wallace Laboratories, Inc., 53 Park Place, New York 8, New York

2-Methyl,2-n-amyl-4-hydroxymethyl-1,3-dioxolane, called Glyketal, produced transient diminution of muscular tone and paralysis of voluntary muscles in doses which did not markedly affect respiration and other vital functions. In small doses which did not cause paralysis Glyketal had a marked depressant action on the flexor and crossed extensor reflexes. The normal knee jerk was not affected. The drug counteracted the central excitatory state produced by strychnine. These results indicate that Glyketal has a selective blocking action on the interneurons of the spinal cord.

Submitted on February 21, 1949







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1949 by the American Society for Pharmacology and Experimental Therapeutics.